Momenta Pharma: Encouraging Q1 Report, Concerns Remain [Seeking Alpha]
MOMENTA PHARMACEUTICALS (MNTA)
Last momenta pharmaceuticals earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.momentapharma.com/investor-relations
Company Research
Source: Seeking Alpha
Momenta Pharma: Encouraging Q1 Report, Concerns Remain Shares of Momenta Pharmaceuticals ( MNTA Formerly known primarily as a play on the coming wave of biosimilar treatments, my daily news scan (tidbits of which can be read in the Biotech Recap series) led me to review Momenta's first quarter report and I must say I was intrigued. Management has made inroads on progressing the wholly-owned pipeline of promising drug candidates, including anti-FcRn IgG1 monoclonal antibody M281 currently in mid-stage studies for treating multiple autoimmune indications. This program might appear vaguely familiar to ROTY members as a big prior winner for us was argenx ( ARGX While it is true that Momenta is not in a front-runner position, given the validated biology here, I'd still like to dig deeper to understand if there's a near to medium-term opportunity for us to take advantage of. Chart daily advanced chart (Source: Finviz) MNTA 15-minute chart (Source: Finviz) When looking at charts, clarity of
Show less
Read more
Impact Snapshot
Event Time:
MNTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNTA alerts
High impacting MOMENTA PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics